305 related articles for article (PubMed ID: 5056661)
1. The pathogenesis of esophageal dysfunction in scleroderma and Raynaud's disease.
Cohen S; Fisher R; Lipshutz W; Turner R; Myers A; Schumacher R
J Clin Invest; 1972 Oct; 51(10):2663-8. PubMed ID: 5056661
[TBL] [Abstract][Full Text] [Related]
2. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
Hostein J; Bost R; Carpentier P; Franco A; Fournet J
Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
[TBL] [Abstract][Full Text] [Related]
3. [Esophageal motor changes in patients with Raynaud's phenomenon and suspected scleroderma. Electromanometric and serologic evaluations].
Benevento A; Barcellini W; Maestri L; Riva R; Sabbadini MG; Veralli E
Minerva Med; 1984 Sep; 75(37):2111-8. PubMed ID: 6483266
[TBL] [Abstract][Full Text] [Related]
4. Role of gastrin supersensitivity in the pathogenesis of lower esophageal sphincter hypertension in achalasia.
Cohen S; Lipshutz W; Hughes W
J Clin Invest; 1971 Jun; 50(6):1241-7. PubMed ID: 5578232
[TBL] [Abstract][Full Text] [Related]
5. Esophageal dysfunction and Raynaud's phenomenon in patients with scleroderma.
Hurwitz AL; Duranceau A; Postlethwait RW
Am J Dig Dis; 1976 Aug; 21(8):601-6. PubMed ID: 952273
[TBL] [Abstract][Full Text] [Related]
6. Esophageal motor abnormalities in children and adolescents with scleroderma and mixed connective tissue disease.
Flick JA; Boyle JT; Tuchman DN; Athreya BH; Doughty RA
Pediatrics; 1988 Jul; 82(1):107-11. PubMed ID: 3288952
[TBL] [Abstract][Full Text] [Related]
7. Endothelial and adrenergic dysfunction in Raynaud's phenomenon and scleroderma.
Freedman RR; Girgis R; Mayes MD
J Rheumatol; 1999 Nov; 26(11):2386-8. PubMed ID: 10555897
[TBL] [Abstract][Full Text] [Related]
8. [Esophageal motility, systemic scleroderma and Raynaud's phenomenon].
Gosselin A
Gastroenterol Clin Biol; 1985 Feb; 9(2):127-9. PubMed ID: 3979733
[No Abstract] [Full Text] [Related]
9. Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients.
Yarze JC; Varga J; Stampfl D; Castell DO; Jimenez SA
Am J Gastroenterol; 1993 Jun; 88(6):870-6. PubMed ID: 8503383
[TBL] [Abstract][Full Text] [Related]
10. Esophageal manometric findings in autoimmune rheumatic diseases: is scleroderma esophagus a specific entity?
Tsianos EB; Drosos AA; Chiras CD; Moutsopoulos HM; Kitridou RC
Rheumatol Int; 1987; 7(1):23-7. PubMed ID: 3495853
[TBL] [Abstract][Full Text] [Related]
11. Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension.
Wigley FM
Curr Opin Rheumatol; 1996 Nov; 8(6):561-8. PubMed ID: 9018460
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic stimulation induces asynchrony between the circular and longitudinal muscle contraction during esophageal peristalsis.
Korsapati H; Babaei A; Bhargava V; Mittal RK
Am J Physiol Gastrointest Liver Physiol; 2008 Mar; 294(3):G694-8. PubMed ID: 18187516
[TBL] [Abstract][Full Text] [Related]
13. Abnormal responses to endothelial agonists in Raynaud's phenomenon and scleroderma.
Freedman RR; Girgis R; Mayes MD
J Rheumatol; 2001 Jan; 28(1):119-21. PubMed ID: 11196511
[TBL] [Abstract][Full Text] [Related]
14. Use of biofeedback training in treatment of Raynaud's disease and phenomenon.
Yocum DE; Hodes R; Sundstrom WR; Cleeland CS
J Rheumatol; 1985 Feb; 12(1):90-3. PubMed ID: 3981523
[TBL] [Abstract][Full Text] [Related]
15. The genesis of lower esophageal sphincter pressure: its identification through the use of gastrin antiserum.
Lipshutz W; Hughes W; Cohen S
J Clin Invest; 1972 Mar; 51(3):522-9. PubMed ID: 5011098
[TBL] [Abstract][Full Text] [Related]
16. Altered lower esophageal sphincter function during early pregnancy.
Fisher RS; Roberts GS; Grabowski CJ; Cohen S
Gastroenterology; 1978 Jun; 74(6):1233-7. PubMed ID: 648814
[TBL] [Abstract][Full Text] [Related]
17. [Hemodynamic response of the digital artery to heat and cold in normal subjects, in systemic scleroderma and in Raynaud's disease].
Vayssairat M; Mathieu JF; Housset E
J Mal Vasc; 1984; 9(1):7-10. PubMed ID: 6707534
[TBL] [Abstract][Full Text] [Related]
18. Esophageal motility studies in patients with Raynaud's phenomenon.
Fitzgerald OM; Bongiovanni G; Hess EV; Merhar G; Fernandez-Ulloa M; Spencer-Green G
J Rheumatol; 1987 Apr; 14(2):273-7. PubMed ID: 3598996
[TBL] [Abstract][Full Text] [Related]
19. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
[TBL] [Abstract][Full Text] [Related]
20. Cooling-induced contraction and protein tyrosine kinase activity of isolated arterioles in secondary Raynaud's phenomenon.
Furspan PB; Chatterjee S; Mayes MD; Freedman RR
Rheumatology (Oxford); 2005 Apr; 44(4):488-94. PubMed ID: 15695304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
